Literature DB >> 3954896

Natural killer cell response to regional lymph node metastases.

S P Schantz, L Poisson.   

Abstract

A determination of natural killer cell activity was performed in 67 individuals with advanced head and neck cancer. The mean activity of 28 patients clinically staged T3 NO or T4 NO was 81 +/- 11 lytic units (LU), significantly higher than 39 patients with palpable lymph node metastases (54 +/- 5 LU). Assessing patients by extent of nodal disease revealed that activity actually increased, though not significantly, with progressive N-staging. A major determinate of increased natural killer cell cytotoxicity in patients with lymph node metastases was extranodal cancer within the neck. The mean activity of nine patients whose tumor was fixed to underlying structures or adherent to skin was 87 +/- 15 LU, significantly higher than the 45 +/- 4 LU mean value of the remaining patients with clinically determined regional nodal disease. The potential clinical implications of these findings are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3954896     DOI: 10.1001/archotol.1986.03780050069012

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.

Authors:  S P Schantz; B W Brown; E Lira; D L Taylor; N Beddingfield
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Producing Capabilities of Interferon-gamma and Interleukin-10 in Peripheral Blood from Oral Squamous Cell Carcinoma Patients.

Authors:  Kosuke Naganawa; Eiji Takayama; Makoto Adachi; Kenji Mitsudo; Masaki Iida; Masako Kamiya-Mizuno; Harumi Kawaki; Masao Ichinose; Masayuki Motohashi; Yasunori Muramatsu; Iwai Tohnai; Shin-Ichiro Sumitomo; Michio Shikimori; Nobuo Kondoh
Journal:  Open Dent J       Date:  2015-03-31

Review 3.  Progression of Metastasis through Lymphatic System.

Authors:  Hengbo Zhou; Pin-Ji Lei; Timothy P Padera
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.